Key result
Aging is linked to an absolute ~0.4% decline in femoral artery FMD per decade.
Why the study?
Femoral artery endothelial function is a promising biomarker of lower extremity vascular health, but the impact of age on femoral artery endothelial function had not been reported in healthy adults.
Does common femoral artery flow-mediated dilation (FA-FMD) decline with age to a similar degree as brachial artery FMD (BA-FMD) in healthy non-smoking adults?
Cross-Sectional (n=70)
No
Does common femoral artery flow-mediated dilation (FA-FMD) decline with age to a similar degree as brachial artery FMD (BA-FMD) in healthy non-smoking adults?
In healthy adults, femoral artery endothelial function (FA-FMD) can be reproducibly measured with calf occlusion and declines with age at a rate similar to the brachial artery (-0.36%/decade), while age-related femoral enlargement frequently reduces wall shear stress to pro-atherogenic levels (<5 dyne/cm2 in 40% of adults >40 years), helping explain age-related predisposition to PAD.
Answers are grounded in this paper and cite their sources.
FA-FMD declines with age similarly to BA-FMD; leaves open its added prognostic value for PAD beyond BA-FMD in prospective cohorts.
Femoral artery (FA) endothelial function is a promising biomarker of lower extremity vascular health for peripheral artery disease (PAD) prevention and treatment; however, the impact of age on FA endothelial function has not been reported in healthy adults. Therefore, we evaluated the reproducibility and acceptability of flow-mediated dilation (FMD) in the FA and brachial artery (BA) (n = 20) and performed cross-sectional FA- and BA-FMD measurements in healthy non-smokers aged 22−76 years (n = 50). FMD protocols demonstrated similar good reproducibility. Leg occlusion was deemed more uncomfortable than arm occlusion; thigh occlusion was less tolerated than forearm and calf occlusion. FA-FMD with calf occlusion was lower than BA-FMD (6.0 ± 1.1% vs 6.4 ± 1.3%, p = 0.030). Multivariate linear regression analysis indicated that age (−0.4%/decade) was a significant independent predictor of FA-FMD (R2 = 0.35, p = 0.002). The age-dependent decline in FMD did not significantly differ between FA and BA (pinteraction agexlocation = 0.388). In older participants, 40% of baseline FA wall shear stress (WSS) values were <5 dyne/cm2, which is regarded as pro-atherogenic. In conclusion, endothelial function declines similarly with age in the FA and the BA in healthy adults. The age-dependent FA enlargement results in a critical decrease in WSS that may explain part of the age-dependent predisposition for PAD.
No takes yet. Share an insight, caveat, or question.
Bapir et al. (2022) conducted a cross-sectional in Healthy non-smoking adults evaluated for lower extremity vascular health and age-related endothelial function (n=70). Age and common femoral artery flow-mediated dilation (FA-FMD with calf occlusion) vs. Brachial artery flow-mediated dilation (BA-FMD with forearm occlusion) was evaluated on Common femoral artery flow-mediated dilation (FA-FMD) vs brachial artery flow-mediated dilation (BA-FMD) and age-dependent decline (MD -0.5%, p=0.030). Age independently predicted a decline in femoral artery FMD of 0.36% per decade, which was lower overall than brachial artery FMD.
Synapse has enriched 10 related papers. Consider them for comparative context: